There is a nice initiative now in Budapest dedicated to the present and future of high technology: a new private university momentarily dubbed as Aquincum Institute of Technology (AIT) will be built near to the Graphisoft Park in Óbuda (Aquincum) concentrating on competitive information-/biotechnology (mainly bioinformatics) education and entrepreneurship. The main instigator of the project… Continue reading Aquincum Institute of Technology, Budapest, IT & BT shaking hands
As the second operation of building my genetically well informed future yesterday (2 days after completing the order) I collected 2 ml of my saliva with the help of 23andMe’s Oragene DNA self-collection kit manufactured by DNA Genotek. First operation has been the sequencing of the D-loop of my mitochondrial DNA out of 5 ml… Continue reading My personalized genetics: 2 ml saliva FedExed to 23andMe!
If “Science has a really serious marketing problem” as Larry Page observed, then life extension technologies face even bigger marketing problems. I am definitely not a marketing expert but realized the problem early on when thinking about the lag-phase period of a robust life extension technology. So I made a short email interview with Dave… Continue reading The marketing problem of life extension technologies
Andrew Chen, founder of CoNotes said that to my mailbox: “I’m basically trying to solve the problem that startups have in hiring the right people. A lot of it has to do with marketing (it’s hard for startups to get prominence over big named companies particularly in university settings), but also fit.“ And that is… Continue reading Do you want a startuppy job: ask CoNotes or not!
It’s my first real encounter with a situation in which the officials of the state of California are clearly against innovation for financial reasons obvious enough (is enough): Wired Science, Alexis Madrigal, upcoming BioBarCamper: Exclusive: DNA Tester Reveals Cease-and-Desist Letter Wired.com has obtained a copy of the cease-and-desist letter sent to Navigenics by the state… Continue reading Innovation stop: “All they’ve done is created an extra billing event for the doctor”
It’s official: The California Department of Public Health wants practicing physicians (many of them prehistorically, sorry, traditionally trained) to be the patres familias in issues between personal genetic test takers and direct-to-consumer personal genetic testing start-ups while declining the test takers’ right to get familiar with their own genetic makeup and risks by their own.… Continue reading Future stop: California health officials against personal genetics risk-takers
“We really think that we can change Health Care…I want to change it in 5 years…it has to change and that’s we all are about” – says Anne Wojcicki, 23andMe co-founder, in the Google Tech Talk on Googling the Googlers’ DNA: A Demonstration of the 23andMe Personal Genome Service. Also a good presentation by Linda… Continue reading The Sergey, Larry, Eric test by Anne & Linda: 23andMe at home
Consumer-Enabled Research, the second goal of pioneering personalized genetics company 23andMe, reached its first generation with the launch of 23andWe. From BusinessWire: “23andWe marks a new approach to genetics research. By directly involving 23andMe customers in the company’s research projects, the goal is to conduct large-scale studies powered by a web-based community of diverse individuals… Continue reading 23andWe follows 23andMe: First generation of Consumer-Enabled Research
from my mailbox: Science-Business eXchange aka SciBX is a new publication from the makers of Nature and BioCentury that aims to improve the translation of today’s science into tomorrow’s products for the diagnosis, treatment and prevention of disease.
The O’Reilly AlphaTech Ventures Startup Camp is a nice option for the emerging personalized genomics companies or any web-related biotech startups to communicate and cooperate with alpha geeks and early technology adopters. Tim O’Reilly writes: The Thursday and Friday (July 10-11) before this year’s Foo Camp in Sebastopol July 11-13, O’Reilly AlphaTech Ventures will be… Continue reading O’Reilly Startup Camp for geeky biotech startups too!
Wow, I guess it’s time for me to move into the stock market business! Here’s the story via David Bradley’s tweet: Julie Kent, Search Engine Journal, April 21st, 2008: Google Wants to Index Genetic Information, Invests in Second DNA Start-Up In 2007, Google made headlines when they invested $4.4 million in 23andMe, a genetic screening… Continue reading How to predict the future via Twitter: Google invests in Navigenics
1. A start-up is a company with a limited operating history (Wikipedia). 2. Startup search “tracks the web technology ecosystem commonly referenced as “Web 2.0.” We collect facts and figures about new web products, startup companies, key startup employees, and the funding dollars powering their growth.” 3. 23andMe is a pioneering web-based, personalized genomics startup… Continue reading Dear StartupSearch: Is 23andMe a web-based startup or not?
Press release: “We at Life Extension Foundation are pleased to help finance BioTime‘s entry into the field of regenerative medicine. We believe that one of the most important applications of embryonic stem cell technology is the slowing and reversing of aging and age-related disease.
The O’Reilly Emerging Technology Conference (ETech) is on and this year they had a growing number of biotech related sessions. Fellow SciFoo Campers like Hugh Rienhoff and Timo Hannay, Makers like Phil Torrone and Limor Fried, Brain Hackers like Ed Boyden are visiting and many more.
Esther Dyson‘s honest post on getting the genotype-health risk correlation statistics right on The Spittoon blog: What You Can Do for 23andMe (and Future Generations) To learn more, researchers need to collect thousands of genetic profiles – and the health data connected with each of them – to find correlations between the two. That leads… Continue reading The second goal of 23andMe: using customer’s real health data later
Finally back from my Bay Area trip, the workshop I participated turned out to be very stimulating in terms of people and ideas. Also visiting The Blood Knot performance at the American Conservatory Theater and having a drink with Monya&Dan were absolutely delightful. I missed my flight on Saturday, so I slept in LA (and… Continue reading Bubble City’s South Park: geek tourism
The pioneer biological video publishing site JoVE (covered here many times) will soon launch a blogging platform and a community site. Nikita Bernstein, the main nerd behind JoVE is building the code and the platform – as Anne Kushnir informed me – should hopefully go live in the next couple of weeks. At least that… Continue reading Will JoVE’s new science blog service reinvent the genre?
The personal genomics service 23andMe just launched publicly a corporate blog called The Spittoon that has been internally up for a few weeks. It is a new chapter in biotech corporate blogging. Just like the web page of 23andMe, The Spittoon’s WordPress blog platform, the concept and design is excellent: amongst others you can find… Continue reading The Spittoon: the eminent corporate blog of 23andMe and Consumer Enabled Research
Jon Rowley is a senior manager at Aastrom Biosciences with a long experience in the not too old Regenerative Medicine field. I am pleased to introduce here his new blog The Regeneration Station as one of the first biotech – regmed blog written by an industrial expert who will share with us his insights on… Continue reading The Regeneration Station – a biotech blog by Aastrom’s Jon Rowley
Elrond: Strangers from distant lands, friends of old you have been summoned here to answer the threat of Mordor. Middle Earth stands upon the brink of destruction, none can escape it. You will unite or you will fall. Each race is bound to this fate, this one doom. Bring forth the ring, Frodo. [Frodo puts… Continue reading Web entrepreneurs and biotech: strangers from distant lands
“We are all from the same seed” – Kara Swisher summarizes what she heard from Linda Avey, co-founder of web based personal genome service 23andMe in the video interview below. Linda and the other founder Anne Wojcicki just talked about the company’s ancestry, genetic comparison and similarity seeking services, the ones that will technologically turned… Continue reading 23andMe: Genetics brings people together, rather than differentiate
From the press release: The co-founders of 23andMe, the first, web-based personal genome service, Linda Avey and Anne Wojcicki will hold a webcast media briefing on Monday, November 19, 2007 at 11:00 am PST/2:00 pm EST. (via The Genetic Genealogist)
After Jobs-Wozniak, Yang-Filo, Brin-Page, it’s time to memorize the names of the co-founders of 23andMe, the first personalized genome service, who are turning the tech establishment into a biotech mode. The new faces of Silicon Valley: the age of Blue Jeans/Black T-Shirt co-founder computer nerds is over, welcome to the era of stylish, well-dressed genetics-savvy… Continue reading The new faces of Silicon Valley: biotech-savvy co-founders Avey-Wojcicki
Show me your feed reading habits and I’ll tell you who you are! I hope this statement is not true as according the item reading trends on Google Reader I have been a serious Valleywag addict in the last 30 days and more, I suspect. Although extensively reading a funny, well-informed but malicious tech gossip… Continue reading Feed reading trends: I am a Valleywag addict, help me!
In the unique state of California there is now an offer for individuals to place orders from October 3 during a $250 million sale of state debt to fund embryonic stem-cell research. The minimum bet is $5,000 and over 1 million you need special permission (just like buying more than 2 iPhones in the early… Continue reading United State of California: buy bonds in stem cell research
Linda Powers is the managing director and co-founder of Toucan Capital Corp, a $120 million venture capital fund (SBIC) focused on seed and early-stage life science and advanced technology investments (the fund markets itself as the The Leading US Investor in Stem Cells and Regenerative Medicine). Out of here insights and facts presented on the… Continue reading SENS3: The stem cell marketplace by Linda Powers, Tucan Capital (slides)
I just got back to my Uptown New Orleans apartment from the 5300 Tchoupitoulas St. Cingular store, where I was unable to buy the last 4 gig iPhone. Why? I do not have an American social security number yet as I’ve just arrived to the States 2 weeks ago and applied for the SSN last… Continue reading Why I failed as the 42nd in the iPhone line and why it is not a problem
Earlier: BioTech(nically), Business 2.0’s new biotech blog
In the age of compelling technology analogies and nomenclatures it was unavoidable that somebody at last identifies enough differences in the history of industrial regenerative medicine to tell Regenerative Medicine 1.0 from 2.0. The man behind is Chris Mason, Group Leader of Stem Cell + Regenerative Medicine Bioprocessing Unit, University College London and cofounder and… Continue reading Are we really in the age of Regenerative Medicine 2.0? A comparison by Chris Mason
I’ve just realized how cool is Cell magazine May 4 issue’s cover (the one with the Scientist Enter the Blogosphere report by Laura Bonetta) with the S-nitrosothiol superhero T-shirt. This substance may have some therapeutic utility in diseases such as heart failure and asthma. Illustration: Cell and me this morning. Cartoons are terrific education tools,… Continue reading Cell’s Superhero Cover: the role of comics in science popularization
Check out Business 2.0’s 100 fastest growing tech companies and read the excellent little summaries on the first 25 out of which 5 are medical related. In regenerative medicine LifeCell has a high position with competitors like Genentech (here think about the recent 23andMe story), Amgen Inc, Gilead Sciences.
If you are busy building a professional career and want things to get done, it’s time to forget MySpace, Facebook or any other social networking 1.0 sites, that are focusing on friendship, love, spam whatever with a general membership. What you need is social networking 2.0, which is based on the special profession you’re in,… Continue reading Nature Network Global Beta and social networking 2.0 for scientists
That’s what the geeky population of the world is waiting for a long time: Powercast‘s dime-size receiver embedded in any low voltage device can turn radio waves into DC voltage coming from a transmitter in a wall. The soul of the product is John Shearer’s invention. “He figured much of the energy bouncing off walls… Continue reading Recharging your laptop with broadcasting power through the air